These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9223533)

  • 1. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke.
    Guéniau C; Oberlander C
    J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of niravoline (RU 51599), a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion.
    Bemana I; Nagao S
    J Neurotrauma; 1998 Feb; 15(2):117-24. PubMed ID: 9512087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.
    Bellissant E; Denolle T; Sinnassamy P; Bichet DG; Giudicelli JF; Lecoz F; Gandon JM; Allain H
    J Pharmacol Exp Ther; 1996 Jul; 278(1):232-42. PubMed ID: 8764356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.
    Chen CH; Toung TJ; Sapirstein A; Bhardwaj A
    J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niravoline, a selective kappa-opioid receptor agonist effectively reduces elevated intracranial pressure.
    Nagao S; Bemana I; Kuratani H; Takahashi E; Nakamura T
    Exp Brain Res; 2000 Feb; 130(3):338-44. PubMed ID: 10706433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
    Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
    Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats.
    Baskin DS; Widmayer MA; Browning JL; Heizer ML; Schmidt WK
    Stroke; 1994 Oct; 25(10):2047-53; discussion 2054. PubMed ID: 7916503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide.
    Zeynalov E; Nemoto M; Hurn PD; Koehler RC; Bhardwaj A
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):414-20. PubMed ID: 16049424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists].
    Ugdyzhekova DS; Maslov LN; Krylatov AV; Lishmanov IuB; Tam SV
    Eksp Klin Farmakol; 2001; 64(4):17-20. PubMed ID: 11589101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
    Gu B; Fraser MO; Thor KB; Dolber PC
    J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist.
    Silvia RC; Slizgi GR; Ludens JH; Tang AH
    Brain Res; 1987 Feb; 403(1):52-7. PubMed ID: 3030502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of pharmacological profile of selective kappa-opioid agonist K-II and U-50488].
    Lu SN; Ma SC; Zhang KG; Dong YX; Cui YY; Li JG; Wang CQ
    Yao Xue Xue Bao; 1991; 26(3):171-4. PubMed ID: 1957656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia.
    Charron C; Messier C; Plamondon H
    Physiol Behav; 2008 Feb; 93(3):502-11. PubMed ID: 18031772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis.
    Moreau R; Cailmail S; Hamon G; Lebrec D
    J Gastroenterol Hepatol; 1996 Sep; 11(9):857-63. PubMed ID: 8889966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
    Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
    Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.